Glaxosmithkline News: Read Latest News & Live Updates on Glaxosmithkline, Photos, Videos at CNBCTV18.com

homeGlaxosmithkline News

Glaxosmithkline NEWS

All

healthcare | May 27, 2021 3:01 PM IST
COVID-19: USFDA gives emergency use approval to Sotrovimab for treating moderate cases
healthcare | May 17, 2021 11:58 AM IST
Sanofi-GSK reports success in virus vaccine, after setback
healthcare | Feb 26, 2021 11:43 PM IST
Novartis assesses re-entry into vaccines
healthcare | Feb 3, 2021 4:29 PM IST
GSK, CureVac team up to develop vaccine against COVID-19 variants
healthcare | Dec 11, 2020 3:31 PM IST
Sanofi, GSK say COVID-19 vaccine won't be ready until late 2021
healthcare | Oct 28, 2020 12:55 PM IST
GSK, Sanofi to make 200 million doses available for COVID-19 vaccine alliance
healthcare | Oct 21, 2020 11:12 AM IST
GSK to launch late-stage testing of syncytial virus vaccine
healthcare | Sept 3, 2020 3:06 PM IST
Sanofi, GlaxoSmithKline in vaccine human trials
market | May 7, 2020 12:54 PM IST
HUL falls 5% after GSK sells stake via block deals
market | Jan 29, 2020 2:24 PM IST
Market analyst Aditya Agarwala of Yes Securities recommends buy on these stocks
business | Dec 16, 2019 12:49 PM IST
GlaxoSmithKline to sell stake in Hindustan Unilever: Report
healthcare | Sept 20, 2019 4:40 PM IST
Corporate tax cut: Here's how pharmaceutical companies will benefit
market | Mar 18, 2019 10:09 AM IST
HUL may see short-term blip in demand, volume growth expected at 8% for Q4FY19: Motilal Oswal
retail | Feb 20, 2019 5:47 PM IST
HUL-GSK deal a good strategic fit, says former Unilever CEO Paul Polman
retail | Dec 3, 2018 10:36 PM IST
HUL buys Horlicks: The fine print

Glaxosmithkline NEWS

COVID-19: USFDA gives emergency use approval to Sotrovimab for treating moderate cases

Sanofi-GSK reports success in virus vaccine, after setback

Novartis assesses re-entry into vaccines

GSK, CureVac team up to develop vaccine against COVID-19 variants

Sanofi, GSK say COVID-19 vaccine won't be ready until late 2021

GSK, Sanofi to make 200 million doses available for COVID-19 vaccine alliance

GSK to launch late-stage testing of syncytial virus vaccine

Sanofi, GlaxoSmithKline in vaccine human trials

HUL falls 5% after GSK sells stake via block deals

Market analyst Aditya Agarwala of Yes Securities recommends buy on these stocks

GlaxoSmithKline to sell stake in Hindustan Unilever: Report

Corporate tax cut: Here's how pharmaceutical companies will benefit

HUL may see short-term blip in demand, volume growth expected at 8% for Q4FY19: Motilal Oswal

HUL-GSK deal a good strategic fit, says former Unilever CEO Paul Polman

HUL buys Horlicks: The fine print